Skip to content
Nonprofiteer
← CYSTIC FIBROSIS FOUNDATION

Form 990 for tax year 2023

Filed by CYSTIC FIBROSIS FOUNDATION.

Totals

Total revenue
$292,016,280
Total expenses
$443,404,599
Contributions and grants received
$86,607,373
Grants paid
$200,455,461
Program service revenue
$3,437,695
Investment income
$179,149,610
Other revenue
$22,821,602
Total assets, end of year
$4,885,921,122
Total liabilities, end of year
$292,964,822
Net assets or fund balances, end of year
$4,592,956,300
Program services expenses (Part IX)
$361,812,102
Management and general expenses
$49,216,974
Fundraising expenses
$32,375,523
Program service expenses (Part III)
$361,812,102

Program services were 81.6% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1a · Federated campaigns

    $270,118

  • 1c · Fundraising events

    $53,390,590

  • 1f · All other contributions, gifts and grants

    $32,946,665

  • 1g · Noncash contributions included above

    $10,370,204

  • 2a · Program service revenue: SCIENTIFIC CONFERENCE

    total $3,103,695 · related or exempt $3,103,695

  • 2b · Program service revenue: DATA SAFETY MONITORING

    total $334,000 · related or exempt $334,000

  • 3 · Investment income

    total $76,349,644 · unrelated business $8,541,916 · excluded $67,807,728

  • 5 · Royalties

    total $12,545,463 · related or exempt $229,359 · excluded $12,316,104

  • 7a · Gross sales of assets other than inventory

    securities $1,606,458,282

  • 7b · Less cost or other basis and sales expenses

    securities $1,503,658,316

  • 7c · Gain or loss

    securities $102,799,966

  • 7d · Net gain or loss

    total $102,799,966 · excluded $102,799,966

  • 8a · Fundraising events: gross income

    $14,594,252

  • 8a · Fundraising events: contributions included on line 1c

    $53,390,590

  • 8b · Fundraising events: direct expenses

    $14,594,252

  • 8c · Net income from fundraising events

    total $0

  • 9a · Gaming: gross income

    $21,710

  • 9b · Gaming: direct expenses

    $11,349

  • 9c · Net income from gaming

    total $10,361 · excluded $10,361

  • 11a · Other revenue: REFUND/CANCELED GRANTS

    total $10,235,107 · related or exempt $10,235,107

  • 11b · Other revenue: OTHER MISC REVENUE

    total $30,671 · excluded $30,671

  • 11e · Other revenue, total

    $10,265,778

Functional expenses

Part IX, the statement of functional expenses.

  • 1 · Grants to domestic organizations and governments

    total $186,907,445 · program services $186,907,445

  • 2 · Grants to domestic individuals

    total $342,968 · program services $342,968

  • 3 · Grants to foreign organizations and individuals

    total $13,205,048 · program services $13,205,048

  • 5 · Compensation of officers, directors and key employees

    total $7,141,874 · program services $3,835,249 · management and general $1,994,317 · fundraising $1,312,308

  • 6 · Compensation of disqualified persons

    total $567,040 · program services $304,505 · management and general $158,342 · fundraising $104,193

  • 7 · Other salaries and wages

    total $90,365,830 · program services $48,316,291 · management and general $25,361,237 · fundraising $16,688,302

  • 8 · Pension plan contributions

    total $7,114,223 · program services $3,942,789 · management and general $1,912,780 · fundraising $1,258,654

  • 9 · Other employee benefits

    total $16,308,874 · program services $8,846,577 · management and general $4,500,717 · fundraising $2,961,580

  • 10 · Payroll taxes

    total $6,455,402 · program services $3,576,339 · management and general $1,610,993 · fundraising $1,268,070

  • 11b · Fees: legal

    total $299,115 · program services $23,140 · management and general $275,507 · fundraising $468

  • 11c · Fees: accounting

    total $463,476 · management and general $463,476

  • 11d · Fees: lobbying

    total $803,465 · program services $803,465

  • 11e · Fees: professional fundraising services

    total $176,400 · fundraising $176,400

  • 11f · Fees: investment management

    total $2,657,320 · management and general $2,657,320

  • 11g · Fees: other

    total $6,394,897 · program services $4,799,509 · management and general $1,562,035 · fundraising $33,353

  • 12 · Advertising and promotion

    total $27,455 · program services $9,060 · management and general $4,667 · fundraising $13,728

  • 13 · Office expenses

    total $5,682,132 · program services $3,245,372 · management and general $424,652 · fundraising $2,012,108

  • 14 · Information technology

    total $13,032,957 · program services $7,462,272 · management and general $2,721,270 · fundraising $2,849,415

  • 16 · Occupancy

    total $7,666,750 · program services $4,851,778 · management and general $1,358,001 · fundraising $1,456,971

  • 17 · Travel

    total $2,978,569 · program services $1,843,875 · management and general $574,877 · fundraising $559,817

  • 19 · Conferences, conventions and meetings

    total $8,660,244 · program services $7,027,449 · management and general $533,069 · fundraising $1,099,726

  • 22 · Depreciation, depletion and amortization

    total $2,742,703 · program services $2,051,076 · management and general $395,123 · fundraising $296,504

  • 23 · Insurance

    total $720,002 · program services $467,811 · management and general $222,979 · fundraising $29,212

  • 24a · Other expenses: CONTRACTED RESEARCH

    total $58,687,072 · program services $58,687,072

  • 24b · Other expenses: TRAINING

    total $503,760 · program services $319,681 · management and general $124,205 · fundraising $59,874

  • 24e · All other expenses

    total $3,499,578 · program services $943,331 · management and general $2,361,407 · fundraising $194,840

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $825 · end of year $20,000

  • 2 · Savings and temporary cash investments

    beginning of year $89,344,692 · end of year $109,087,327

  • 3 · Pledges and grants receivable

    beginning of year $16,374,636 · end of year $15,055,739

  • 4 · Accounts receivable

    beginning of year $23,189,779 · end of year $22,382,858

  • 8 · Inventories for sale or use

    beginning of year $209,153 · end of year $206,966

  • 9 · Prepaid expenses and deferred charges

    beginning of year $5,923,684 · end of year $4,831,329

  • 10a · Land, buildings and equipment: cost or other basis

    $32,090,841

  • 10b · Land, buildings and equipment: accumulated depreciation

    $23,227,804

  • 10c · Land, buildings and equipment, net

    beginning of year $10,429,968 · end of year $8,863,037

  • 11 · Investments: publicly traded securities

    beginning of year $2,713,899,331 · end of year $2,705,339,108

  • 12 · Investments: other securities

    beginning of year $1,734,329,559 · end of year $1,764,791,266

  • 13 · Investments: program-related

    beginning of year $75,899,728 · end of year $88,133,200

  • 15 · Other assets

    beginning of year $65,457,637 · end of year $167,210,292

  • 17 · Accounts payable and accrued expenses

    beginning of year $32,393,816 · end of year $37,939,543

  • 18 · Grants payable

    beginning of year $226,137,686 · end of year $226,220,440

  • 19 · Deferred revenue

    beginning of year $2,196,254 · end of year $2,685,701

  • 25 · Other liabilities

    beginning of year $30,612,220 · end of year $26,119,138

  • 27 · Net assets without donor restrictions

    beginning of year $4,421,196,361 · end of year $4,576,101,051

  • 28 · Net assets with donor restrictions

    beginning of year $22,522,655 · end of year $16,855,249

Mission and programs · 2023

Mission

SEE SCHEDULE O

Activities or mission (Part I)

TO CURE CYSTIC FIBROSIS (CF) AND TO PROVIDE ALL PEOPLE WITH CF THE (CONTINUED ON SCH O) OPPORTUNITY TO LEAD LONG, FULFILLING LIVES.

  • SEE SCHEDULE O

    Expenses $317,894,830 · Grants $193,918,675 · Revenue $13,902,161

  • SEE SCHEDULE O

    Expenses $23,754,437 · Grants $6,194,892

  • SEE SCHEDULE O

    Expenses $20,162,835

As filed on the 2023 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

  • Louis A Defalco

    VICE CHAIR

    Total calculated
    $0
    Hours/week
    5
  • Carole B Griego MD

    TRUSTEE

    Total calculated
    $0
    Hours/week
    3
  • Kate O'Donnell

    TRUSTEE

    Total calculated
    $0
    Hours/week
    3
  • Dodzie Sogah PhD

    TRUSTEE

    Total calculated
    $0
    Hours/week
    3
  • David A Mount

    TREASURER

    Total calculated
    $0
    Hours/week
    3
  • Robert H Niehaus

    VICE CHAIR

    Total calculated
    $0
    Hours/week
    5
  • Eric R Olson PhD

    VICE CHAIR

    Total calculated
    $0
    Hours/week
    5
  • Dominic J Caruso

    TRUSTEE

    Total calculated
    $0
    Hours/week
    3
  • Paul A Motenko

    TRUSTEE

    Total calculated
    $0
    Hours/week
    3
  • Teresa L Elder

    VICE CHAIR

    Total calculated
    $0
    Hours/week
    5
  • Eric Schneider MD

    TRUSTEE

    Total calculated
    $0
    Hours/week
    3
  • Steven Shak MD

    TRUSTEE

    Total calculated
    $0
    Hours/week
    3
  • John S Weinberg

    EXECUTIVE VICE CHAIR

    Total calculated
    $0
    Hours/week
    5
  • Kc Bryan White

    CHAIR

    Total calculated
    $0
    Hours/week
    8
  • Jessica H Boyd MD

    TRUSTEE

    Total calculated
    $0
    Hours/week
    3
  • Michael P Boyle MD

    PRESIDENT & CEO

    Total calculated
    $1,472,782
    From this org
    $1,372,546
    From related orgs
    $0
    Other
    $100,236
    Hours/week
    40 + 1 related

    Schedule J breakdown matched by us

    Base
    $678,428
    Bonus
    $384,290
    Other
    $309,828
    Deferred
    $45,745
    Nontaxable benefits
    $54,491
    Filer's total
    $1,472,782
  • Irena Barisic

    EVP, CHIEF OPER/FIN OFFICER

    Total calculated
    $742,637
    From this org
    $692,433
    From related orgs
    $0
    Other
    $50,204
    Hours/week
    40 + 1 related

    Schedule J breakdown matched by us

    Base
    $576,604
    Bonus
    $114,689
    Other
    $1,140
    Deferred
    $48,033
    Nontaxable benefits
    $2,171
    Filer's total
    $742,637
  • Michael B Cavadel

    SVP, CHIEF LEGAL OFFICER

    Total calculated
    $576,547
    From this org
    $494,693
    From related orgs
    $0
    Other
    $81,854
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $447,893
    Bonus
    $45,776
    Other
    $1,024
    Deferred
    $47,929
    Nontaxable benefits
    $33,925
    Filer's total
    $576,547
  • John C Mahler Jr

    CHIEF INVESTMENT OFFICER

    Total calculated
    $2,822,596
    From this org
    $2,747,771
    From related orgs
    $0
    Other
    $74,825
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $731,770
    Bonus
    $1,685,373
    Other
    $330,628
    Deferred
    $33,192
    Nontaxable benefits
    $41,633
    Filer's total
    $2,822,596
  • Bruce Marshall MD

    EVP & CHIEF MEDICAL OFFICER

    Total calculated
    $777,958
    From this org
    $741,926
    From related orgs
    $0
    Other
    $36,032
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $561,070
    Bonus
    $166,024
    Other
    $14,832
    Deferred
    $36,032
    Nontaxable benefits
    $0
    Filer's total
    $777,958
  • John P Clancy MD

    SVP, CLINICAL RESEARCH

    Total calculated
    $749,355
    From this org
    $659,434
    From related orgs
    $0
    Other
    $89,921
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $498,512
    Bonus
    $153,438
    Other
    $7,484
    Deferred
    $37,070
    Nontaxable benefits
    $52,851
    Filer's total
    $749,355
  • Earl A Lee

    MANAGING DIRECTOR, INVESTMENTS

    Total calculated
    $1,397,110
    From this org
    $1,114,424
    From related orgs
    $0
    Other
    $282,686
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $462,638
    Bonus
    $650,071
    Other
    $1,715
    Deferred
    $264,863
    Nontaxable benefits
    $17,823
    Filer's total
    $1,397,110
  • Eric Koehrsen

    MANAGING DIRECTOR, INVESTMENTS

    Total calculated
    $1,218,507
    From this org
    $949,505
    From related orgs
    $0
    Other
    $269,002
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $426,621
    Bonus
    $521,753
    Other
    $1,131
    Deferred
    $214,961
    Nontaxable benefits
    $54,041
    Filer's total
    $1,218,507
  • Andrew Lewis

    MANAGING DIRECTOR, INVESTMENTS

    Total calculated
    $1,318,447
    From this org
    $1,268,837
    From related orgs
    $0
    Other
    $49,610
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $422,884
    Bonus
    $843,750
    Other
    $2,203
    Deferred
    $33,192
    Nontaxable benefits
    $16,418
    Filer's total
    $1,318,447
  • Gentiana S Arovas

    MANAGING DIRECTOR, INVESTMENTS

    Total calculated
    $731,737
    From this org
    $541,296
    From related orgs
    $0
    Other
    $190,441
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $377,927
    Bonus
    $161,385
    Other
    $1,984
    Deferred
    $137,360
    Nontaxable benefits
    $53,081
    Filer's total
    $731,737
  • Albert Faro

    VP CLINICAL AFFAIRS

    Total calculated
    $642,770
    From this org
    $517,875
    From related orgs
    $0
    Other
    $124,895
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $423,333
    Bonus
    $87,989
    Other
    $6,553
    Deferred
    $67,372
    Nontaxable benefits
    $57,523
    Filer's total
    $642,770
  • Preston W Campbell III MD

    FORMER CEO & STRATEGIC ADVISOR

    Total calculated
    $257,491
    From this org
    $241,993
    From related orgs
    $0
    Other
    $15,498
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $44,685
    Bonus
    $63,140
    Other
    $134,168
    Deferred
    $9,274
    Nontaxable benefits
    $6,224
    Filer's total
    $257,491
  • William Skach MD

    EVP & CHIEF SCIENTIFIC OFFICER

    Total calculated
    $279,304
    From this org
    $277,714
    From related orgs
    $0
    Other
    $1,590
    Hours/week
    40

    Schedule J breakdown matched by us

    Base
    $144,310
    Bonus
    $98,922
    Other
    $34,482
    Deferred
    $1,590
    Nontaxable benefits
    $0
    Filer's total
    $279,304

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 3 · Compensation committee
  • 3 · Independent compensation consultant
  • 3 · Form 990 of other organizations
  • 3 · Written employment contract
  • 3 · Compensation survey or study
  • 3 · Approval by the board or compensation committee
  • 4b · Supplemental nonqualified retirement plan
  • 7 · Other non-fixed payments

Answered no

  • 4a · Severance or change-of-control payment
  • 4c · Equity-based compensation arrangement
  • 5a · Pay contingent on this organization's revenues
  • 5b · Pay contingent on a related organization's revenues
  • 6a · Pay contingent on this organization's net earnings
  • 6b · Pay contingent on a related organization's net earnings
  • 8 · Paid under the initial-contract exception

The filer's explanations (Part III)

PART I, LINE 4B:
THE TWO EXECUTIVES LISTED BELOW PARTICIPATE IN A NONQUALIFIED DEFERRED COMPENSATION PLAN, UNDER WHICH INTERESTS ARE FORFEITED BY THE PARTICIPANT IF THE PARTICIPANT VOLUNTARILY TERMINATES EMPLOYMENT PRIOR TO THE DESIGNATED VESTING DATE. INFORMATION REGARDING THE AMOUNT OF PAYMENTS MADE BY THE PLAN DURING THE REPORTING YEAR IS PROVIDED BELOW. NAME: JOHN C. MAHLER JR AMOUNT: $320,595 NAME: MICHAEL P. BOYLE, M.D. AMOUNT: $304,926
PART I, LINE 7:
SEVERAL INDIVIDUALS LISTED IN FORM 990, PART VII, SECTION A, LINE 1A, PARTICIPATED IN THE FOUNDATION'S INCENTIVE COMPENSATION PLAN, FROM WHICH NON-FIXED PAYMENTS NOT DESCRIBED IN LINES 5 AND 6 WERE PAID. THE INCENTIVE COMPENSATION PLAN PAYS NON-FIXED PAYMENTS SUBJECT TO, AND BASED ON, THE ACHIEVEMENTS OF ANNUAL PERFORMANCE OBJECTIVES ESTABLISHED IN ADVANCE BY THE COMPENSATION COMMITTEE OF THE BOARD OF TRUSTEES. IN ADDITION, THE INCENTIVE COMPENSATION PLAN PAYS NON-FIXED PAYMENTS THAT RELATE TO A THREE-YEAR PERFORMANCE PERIOD, SUBJECT TO, AND BASED ON, THE ACHIEVEMENT OF LONG-TERM PERFORMANCE OBJECTIVES ESTABLISHED IN ADVANCE BY THE COMPENSATION COMMITTEE OF THE BOARD. ANY FINANCIAL PERFORMANCE OBJECTIVES ESTABLISHED UNDER THE INCENTIVE COMPENSATION PLAN DO NOT INCLUDE PROGRAM-RELATED REVENUES SUCH AS ROYALTY STREAMS OR LUMP-SUM PAYMENTS, AND SALES PROCEEDS FROM TRANSFER OF THE FOREGOING TO THIRD PARTIES RELATED TO THE DEVELOPMENT AND APPROVAL OF CF DRUGS.

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

The 10 largest by cash amount. The API serves every itemized grant.

Related organizations on this return

Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.

Taxable family on this return

Schedule R Parts I, III and IV, as filed. These record ownership and control, not shared board members or money moved.

Related partnerships

Part III: related organizations taxable as a partnership, with the filer's share.

  • NANTAHALA CAPITAL PARTNERS QR LP

    EXCLUDED · INVESTMENTS · CT · 100% owned · share of income $9,285,933

  • LF-CFF INCUBATOR FUND LP

    EXCLUDED · INVESTMENTS · DE · 100% owned · share of income -$405,351 · share of assets $10,080,405

  • AXAR QR OPPORTUNISTIC CREDIT FUND LP

    EXCLUDED · INVESTMENTS · DE · 99.19% owned · share of income -$77,274 · share of assets $5,922,726

  • LONGWOOD - LF CFF INCUBATOR FND II

    EXCLUDED · INVESTMENTS · DE · 100% owned · share of income -$643,337 · share of assets $178,337

Related corporations and trusts

Part IV: related organizations taxable as a corporation or trust.

  • CHARITABLE REMAINDER TRUST (2)

    T · FIDUCIARY · CA

  • CHARITABLE REMAINDER TRUST

    T · FIDUCIARY · TN

  • CHARITABLE REMAINDER TRUST

    T · FIDUCIARY · NM

  • PERPETUAL TRUST

    T · FIDUCIARY · MA

Provenance

Return type
form_990
Tax year
2023
Filed
11 November 2024
IRS schema version
2023v5.1
Source object
202403179349300720

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.